91 related articles for article (PubMed ID: 12714821)
1. Homogeneous immunoglobulins following allogeneic bone marrow transplantation.
Hajdu M; Puskás E; Sipos A; Barta A; Pálóczi K; Uher F
Acta Haematol; 2003; 109(3):124-8. PubMed ID: 12714821
[TBL] [Abstract][Full Text] [Related]
2. [Restricted antibody diversity after bone marrow transplantation--homogeneous immunoglobulins].
Puskás E; Hajdu M; Barta A; Sipos A; Uher F; Pálóczi K
Orv Hetil; 2001 Feb; 142(6):267-72. PubMed ID: 11243020
[TBL] [Abstract][Full Text] [Related]
3. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
[TBL] [Abstract][Full Text] [Related]
4. Clonal imbalances of serum immunoglobulins after allogeneic bone marrow transplantation: an analysis by high-resolution two-dimensional gel electrophoresis.
Tissot JD; Helg C; Chapuis B; Zubler RH; Jeannet M; Hochstrasser DF; Hohlfeld P; Schneider P
Bone Marrow Transplant; 1992 Oct; 10(4):347-53. PubMed ID: 1422490
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
6. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
Santini V; Zoccolante A; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Martinazzo G; Bernabei PA; Ferrini PR
Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524
[TBL] [Abstract][Full Text] [Related]
7. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
8. Induction of a syngeneic graft-versus-leukemia effect following bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Hows JM; Goldman JM
Leukemia; 1990 Apr; 4(4):287-91. PubMed ID: 2366584
[TBL] [Abstract][Full Text] [Related]
9. Deficit of T-cell recovery after allogeneic bone marrow transplantation in chronic myeloid leukemia patients.
Diamond HR; Souza MH; Bouzas LF; Tabak DG; Campos MM; Câmara FP; Rumjanek VM
Anticancer Res; 1995; 15(4):1553-60. PubMed ID: 7654044
[TBL] [Abstract][Full Text] [Related]
10. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow transplantation in chronic myeloid leukemia].
Hansz J
Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
[TBL] [Abstract][Full Text] [Related]
12. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
[TBL] [Abstract][Full Text] [Related]
14. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy following allogeneic bone marrow transplantation.
Dazzi F; Goldman JM
Annu Rev Med; 1998; 49():329-40. PubMed ID: 9509267
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
17. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.
Norhagen G; Engström PE; Björkstrand B; Hammarström L; Smith CI; Ringdén O
Bone Marrow Transplant; 1994 Aug; 14(2):229-34. PubMed ID: 7994237
[TBL] [Abstract][Full Text] [Related]
18. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Barnett L; Heller G
Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
